Comparative evaluation of subgingivally delivered 1.2% rosuvastatin and 1% metformin gel in treatment of intrabony defects in chronic periodontitis: A randomized controlled clinical trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of periodontology"
DOI: 10.1002/jper.17-0434
Abstract: BACKGROUND The aim of this study is to explore and compare the clinical efficacy of locally delivered 1.2% Rosuvastatin (RSV) and 1% Metformin (MF) gel as an adjunct to scaling and root planning (SRP) in… read more here.
Keywords: intrabony defects; treatment; treatment intrabony; metformin gel ... See more keywords
Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical oral investigations"
DOI: 10.1007/s00784-021-04215-w
Abstract: OBJECTIVE This split-mouth randomized controlled trial aimed to evaluate the effect of enamel matrix derivative (EMD) associated with a simplified papilla preservation flap (SPPF) compared to SPPF alone in the surgical treatment of intrabony defects… read more here.
Keywords: matrix derivative; split mouth; mouth randomized; cal gain ... See more keywords
Efficacy of rh-PDGF-BB and Emdogain with or without DFDBA using M-MIST in the treatment of intrabony defects
Sign Up to like & getrecommendations! Published in 2023 at "Nigerian Journal of Clinical Practice"
DOI: 10.4103/njcp.njcp_1725_21
Abstract: Background: The versatile combination of emdogain or enamel matrix derivative (EMD), recombinant human platelet-derived growth factor-BB (rhPDGF-BB), and demineralized freeze-dried bone allograft (DFDBA) has not been utilized in the treatment of intrabony defects yet. Aim:… read more here.
Keywords: group; intrabony defects; treatment intrabony; dfdba ... See more keywords